In a mouse model in which aortic aneurysm formation was induced by continuous administration of angiotensin II (Ang II), concomitant treatment with a TGF-β neutralizing antibody promoted aortic rupture, mostly at the level of the ascending aorta and suprarenal aortic region. This evidence concerns the gene TGFB1 and aortic aneurysm.